Enterprise Transformation and Operating Model Design
Translate strategic ambition into an executable transformation and sustainable future state.
Explore this serviceJohnson & Johnson · Case study
Regulated Platform and Product Transformation
Connecting regulated product innovation, enterprise platforms, trusted data and controlled market launch.
- Regulated delivery
- Data integration
- Digital products
Context
The transformation environment
Johnson & Johnson was modernising digital platforms and developing research-led consumer health products across UK and EMEA markets. Delivery had to integrate product, engineering, infrastructure, data, identity, marketing, legal and regulatory requirements without compromising compliance or operational control.
The challenge
What had to be resolved
Fragmented platforms, services and consumer data constrained reuse, delivery flow and consistent market execution.
Research-led products depended on trusted external data, secure identity and access capability, and market-specific regulatory approval.
Distributed business and technology teams needed one integrated delivery direction across product development, platform change and launch readiness.
The response
How the transformation was integrated
- 01
Integrate platform and product roadmaps
Mobilised shared roadmaps and governance connecting enterprise platform modernisation with the needs of individual consumer health products and brands.
- 02
Create cross-functional product delivery
Aligned product, engineering, infrastructure, data, marketing, legal and regulatory colleagues around clear outcomes, dependencies and controlled release decisions.
- 03
Connect trusted data and identity
Led delivery involving Met Office data integration and collaboration with Janrain, a US-based Customer Identity and Access Management solutions provider.
- 04
Take research-led products through launch
Led Greenhouse propositions including the Imodium Pollen Count App and IBS Symptom Tracker from discovery through solution design, engineering and controlled deployment across UK and EMEA markets.
Value created
What changed
Established a more integrated platform and product-delivery environment.
Enabled controlled launch of research-led digital health products in regulated markets.
Connected external data, consumer identity and enterprise platforms to usable customer propositions.
Improved the repeatability of delivery and market-readiness governance across distributed teams.
Leadership approach
Governance with direct intervention
Tayo brought business, product, technology and compliance stakeholders into one delivery system, using governance to create visibility and hands-on intervention to resolve the integration points most likely to delay or weaken a controlled market launch.
Discuss a related challenge
Where is delivery confidence weakest in your transformation?
Start with a no-commitment diagnostic conversation about the outcome at risk, the delivery constraint and what leadership needs to see next.
Email Tawose Group